Search & Filter

Women are less likely to receive basic life support for cardiac arrest from members of the public then men, the European Society of Cardiology (ESC) announced today on International Women's Day.

People who smoke are at increased risk of sight loss, and vision experts have used No Smoking Day as an opportunity to remind people about the risks with the launch of a new social media campaign, titled #20Ways.

Heart Research UK has issued a new guide featuring handy hints to avoid second-hand smoke ahead of this year's National No Smoking Day, which takes place on Wednesday 9 March.

People who perceive dementia symptoms as an illness feel more negative than those who see it as an inevitable part of getting older, a new study indicates.

A new add-on treatment for partial onset seizures, with or without secondary generalised seizures, has been authorised in adults with epilepsy. Brivaracetam (Briviact) is an anti-epileptic drug that provides patients, with this particular type of epilepsy, a new opportunity to better manage their seizures.

The National Ankylosing Spondylitis Society (NASS) has launched a new campaign aimed at ophthalmologists, dermatologists and gastroenterologists called Back Pain Plus. 

Marie Curie is calling for NHS England to ensure that the palliative care needs of all cancer patients are assessed when they are first diagnosed. This coincides with the publication of a new Marie Curie report, The Hidden Challenges of Palliative Cancer Care.

A new report by Boehringer Ingelheim into idiopathic pulmonary fibrosis (IPF), entitled Inspiration, has been launched dedicated to raising awareness of the rare disease that is relatively unheard of, frequently misdiagnosed and ittle understood.

Pharmaceutical company UCB has announced that a new add-on treatment for adults with epilepsy, with or without secondary generalised seizures, will be available on the NHS.

Thousands of people in Britain face an uncertain future as they enter old age as they are underprepared to look after themselves if they need social care, a new poll of medical experts has revealed.

Pharmaceutical company UCB has announced new add-on treatment Briviact for adults with partial-onset seizures (POS).

Pharmaceutical company Boehringer Ingelheim has announced two new initiatives to support people living with idiopathic pulmonary fibrosis (IPF).

A new poll of medical experts has highlighted how the knock-on effect of lack of planning for old age will further impact upon stretched NHS resources.

Despite the initial slow uptake of Novel Oral Anticoagulants (NOACs), they will still challenge warfarin as a viable treatment for Venous Thromboembolism (VTE), consulting firm GlobalData has predicted.

Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association (EHRA)/European Society of Cardiology (ESC) survey published  in Europace. The poll of more than 1100 patients with atrial fibrillation found those with no schooling missed treatment targets more often, were less aware of bleeding risks, and did not know they could continue normal daily activities.